The Hydration Pharmaceuticals Co (ASX:HPC) Total Operating Expense: A$6.84 Mil (TTM As of Dec. 2025)


What is The Hydration Pharmaceuticals Co Total Operating Expense?

The Hydration Pharmaceuticals Co ASX:HPC Total Operating Expense is A$6.84 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

The Hydration Pharmaceuticals Co's Total Operating Expense for the six months ended in Dec. 2025 was A$4.41 Mil. The Hydration Pharmaceuticals Co's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$6.84 Mil.

The Hydration Pharmaceuticals Co Total Operating Expense Related Terms

The Hydration Pharmaceuticals Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Total Operating Expense Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
14.38 22.82 19.62 9.19 6.79

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 13.12 5.16 3.77 2.43 4.41

The Hydration Pharmaceuticals Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$6.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of A$6.84 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Total Operating Expense of A$6.84 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Total Operating Expense too high?
The Hydration Pharmaceuticals Co's current Total Operating Expense is A$6.84 Mil.
How does The Hydration Pharmaceuticals Co's Total Operating Expense compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Total Operating Expense of A$6.84 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Retail - Defensive company?
A good Total Operating Expense depends on the Retail - Defensive industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Total Operating Expense is A$6.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Total Operating Expense of A$6.84 Mil. The current Total Operating Expense is A$6.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Total Operating Expense is A$6.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.